Treatment Details
Leronlimab
Overview
LERONLIMAB What is leronlimab. Leronlimab is a medication used to treat the human immunodeficient virus (HIV). It works by blocking the entry of HIV into cells, halting the virus’s replication [1]. The FDA does not approve Leronlimab, which is currently an investigational product. The timing of FDA approval is currently unknown. Can leronlimab be used in long-COVID.
Relevant Studies
Patient – clinicalinfo.hiv.gov
WHO 2019 NCoV Post COVID 19 Condition Clinical Case Definition 2021.1 – www.who.int
PMC8277229 – www.ncbi.nlm.nih.gov
How it works:
Binds to CCR5 to block HIV from infecting cells
Dosage Form: Tablet Unknown - Not FDA approved
Common Usage: HIV-1 infection
Precautions:
Pregnancy
Unknown - in development
Lactation
Unknown - in development
Warnings
Unknown - in development
Write a Review
© 2024 CompendiRx.com. All Rights Reserved. Information on Ratings and Reviews is reported by our members and is not medical advice.
Submission Date: Apr 16, 2024, 07:46AM
Last Update Date: Sep 14, 2024, 07:01PM
![](https://compendirx.com/wp-content/themes/medical-directory-child/assets/img/insta.png")
© 2024 CompendiRx.com. All Rights Reserved. Information on Ratings and Reviews is reported by our members and is not medical advice.
Related Medicines